The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Tuesday 07, June 2022. The committee will meet in open session to discuss an Emergency Use Authorization (EUA) request by submitted by Novavax for a COVID-2019 vaccine (NVX-CoV2373) to prevent COVID-19 infections in individuals 18 years of age and older.